Home / Resource Library / Romidepsin Plus CHOEP Falls Short in Newly Diagnosed Peripheral T-Cell LymphomaRomidepsin Plus CHOEP Falls Short in Newly Diagnosed Peripheral T-Cell Lymphoma ASH 2021